Across TCGA pan-cancer cohorts, DMRTB1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of DMRTB1’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where DMRTB1 RNA is repressed in tumor relative to normal tissue. In most cancer types DMRTB1 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.
THCA, UCEC, and LUAD are the cancer types where DMRTB1 tumor–normal differential expression is most reproducible.